Property Summary

NCBI Gene PubMed Count 486
PubMed Score 2399.72
PubTator Score 2697.10

Knowledge Summary

Patent (54,945)


  Disease Sources (4)

Disease Target Count P-value
ovarian cancer 8492 6.45592071703311E-7
breast carcinoma 1614 1.80460683817933E-6
group 3 medulloblastoma 2254 3.05597381135495E-5
atypical teratoid/rhabdoid tumor 1095 5.84076336796922E-4
Pick disease 1893 6.24446299405638E-4
intraductal papillary-mucinous adenoma (IPMA) 2956 6.36001235686537E-4
primitive neuroectodermal tumor 3031 7.19963264064501E-4
medulloblastoma, large-cell 6234 8.05450066559076E-4
osteosarcoma 7933 8.61793378414987E-4
posterior fossa group B ependymoma 1530 0.00178525549755847
pancreatic ductal adenocarcinoma liver metastasis 1795 0.00452074309418673
intraductal papillary-mucinous neoplasm (IPMN) 3289 0.00608143130805172
ductal carcinoma in situ 1745 0.00720537624999664
invasive ductal carcinoma 2950 0.0373092415682791



Accession Q07869 B0G0X3 Q16241 Q6I9S0 Q92486 Q92689 Q9Y3N1 PPAR-alpha
Symbols PPAR



1KKQ   3SP6   1I7G   1K7L   2NPA   2P54   2REW   2ZNN   3ET1   3FEI   3G8I   3KDT   3KDU   3VI8   4BCR   4CI4   5AZT  

  Ortholog (11)

Species Source
Chimp OMA EggNOG
Macaque OMA EggNOG Inparanoid
Mouse OMA EggNOG Inparanoid
Rat OMA EggNOG Inparanoid
Dog OMA Inparanoid
Horse OMA Inparanoid
Cow OMA Inparanoid
Opossum OMA Inparanoid
Platypus OMA EggNOG
Anole lizard OMA Inparanoid
Xenopus OMA EggNOG

 GO Component (2)

MLP Assay (3)

AID Type Active / Inconclusive / Inactive Description
2277 screening 14 / 0 / 0 Center Based Initiative to identify novel modulators of the Retinoic acid receptor-related Orphan Receptors (ROR): luminescence-based high throughput cell-based assay to identify modulators of human nuclear receptors.
504735 confirmatory 3 / 0 / 3 Late stage assay provider counterscreen for partial agonists of the peroxisome proliferator-activated receptor gamma (PPARg): Luminescence-based cell-based dose response assay for partial agonists of the peroxisome proliferator-activated receptor alpha (PPARA).
504934 other 1 / 0 / 0 Late stage assay provider results from the probe development effort to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): luminescence-based high throughput cell-based assay to identify modulators of human nuclear receptors

Gene RIF (457)

26775637 cPGI2 activates PPARalpha and PPARgamma, which act separately from IP-R to up-regulate the expression of key genes involved in the function of brite adipocytes.
26722456 PPAR-gamma and PTEN expressions are related to the clinical parameters and prognosis of renal cell carcinoma
26718439 PPAR agonists troglitazone and aleglitazar reverse doxorubicin resistance of human myelogenous leukemia cells.
26673968 No association was found between PPARalpha L162V single nucleotide polymorphisms with obesity and metabolic syndrome in a multi-ethnic population in Kampar, Malaysia.
26671025 There was no statistically significant difference in the distribution of PPARalpha Leu162Val polymorphism between the ischemic stroke patients and controls in the Han ethnic group.
26617775 Describe a renoprotective role of fenofibrate in albumin bound fatty acid associated tubular toxicity, involving the transcriptional activation of PPARalpha and suppression of NF-kB.
26577021 These results suggest that EPA inhibits intestinal beta-carotene absorption by down regulation of SR B1 expression via PPARalpha dependent mechanism and provide an evidence for dietary modulation of intestinal beta-carotene absorption.
26556865 PPARalpha functions as an E3 ubiquitin ligase to induce Bcl2 ubiquitination and degradation, leading to increased cancer cell sensitivity in response to chemotherapy drugs.
26497374 results support an important association between rs1800206 minor allele (V) of PPAR alpha and lower CRP level; the interaction analysis showed a combined effect between rs1800206 and rs135539 on the lower CRP level
26472199 Supplementation with the PPARalpha agonist WY14643 improved the homeostasis and barrier function of filaggrin deficient skin models by normalization of the free fatty acid profile.

AA Sequence


Text Mined References (495)

PMID Year Title
26775637 2016 IP-receptor and PPARs trigger the conversion of human white to brite adipocyte induced by carbaprostacyclin.
26722456 2015 Prognostic role of PPAR-? and PTEN in the renal cell carcinoma.
26718439 2015 Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
26673968 2015 Screening of Peroxisome Proliferator-Activated Receptors (PPARs) ?, ? and ? Gene Polymorphisms for Obesity and Metabolic Syndrome Association in the Multi-Ethnic Malaysian Population.
26671025 2016 Functional Genetic Variants of PPARx03B3; and PPAR? Encoding Peroxisome Proliferator-Activated Receptors and Susceptibility to Ischemic Stroke in Chinese Han Population.
26617775 2015 Fenofibrate, a PPAR? agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.
26577021 2016 Eicosapentaenoic acid inhibits intestinal ?-carotene absorption by downregulation of lipid transporter expression via PPAR-? dependent mechanism.
26556865 2015 PPAR? induces cell apoptosis by destructing Bcl2.
26504087 2015 Reactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-? in CD36 Protein Expression and Foam Cell Formation.
26497374 2015 Study on association of peroxisome proliferator-activated receptor ? with C-reactive protein, and additional gene-gene interaction in Chinese Han.